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ABBREVIATIONS 
 
5-ARI: Five alpha reductase inhibitor 
AIP: Asymptomatic inflammatory prostatitis 
BPH: Benign prostatic hyperplasia 
COAD: Chronic obstructive airway disease 
CPPS: Chronic prostatitis/ pelvic pain syndrome 
CRF: Chronic renal failure 
DRE:  Digital rectal examination 
IRB: Institutional review board 
LUTS: Lower urinary tract symptoms 
MI: Myocardial infarction 
MS: Meatal stenosis 
NIH: National Institute of Health 
Pi: Prostatic inflammation 
S.D.:  Standard deviation  
TUR Syndrome: Transurethral resection Syndrome 
TURP: Transurethral resection of the prostate 
US: Urethral stricture 
UTI: Urinary tract infection 
Group A= Absence of prostatic inflammation (Pi-) 
Group B= Presence of inflammation (Pi+) 
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ABSTRACT 
 
AIM:  
 
To evaluate the role of asymptomatic prostatitis found in biopsy 
specimens on the outcome of patients undergoing a TURP for BPH. 
 
PATIENTS AND METHODS: 
 
All patients who had undergone a TURP between 2005 and 2010 in our 
institute for BPH and who had a minimum of 3 months follow-up were 
included. The study population was divided into two cohorts: those with, 
and those without prostatic inflammation. The outcomes between these 
two groups were compared with respect to predefined parameters, 
including demographic data, indication for TURP, positive preoperative 
urine cultures, presence of a urinary catheter, duration of follow-up, 
weight of gland resected, monopolar / bipolar resection, need for blood 
transfusion, emergency re-explorations, TUR syndrome, clot retention, 
recatheterisation; Long term complications like meatal stenosis, urethral 
stricture, bladder neck contracture, and recurrent adenoma were also 
noted. The modified Clavien system for TURP was used for reporting 
complications. 
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RESULTS: 
 
There was no significant difference between both the groups both with 
respect to long-term and short term complications. 
 
CONCLUSIONS: 
 
Prostatic inflammation may be a co-incidental finding in the biopsy of 
patients undergoing a TURP. The association between both short term 
and term complications and the presence of prostatitis could not be 
demonstrated in our study. Larger prospective trials may be needed to 
further validate these findings. 
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INTRODUCTION 
 
The co-existence of inflammation and BPH in the prostate is well-
known, although the significance of histologically proven prostatic 
inflammation and its relationship with BPH is not well-understood1. 
While prostatic inflammation may play a role as an inciting even in the 
development of BPH nodules, its role as the next link in the chain of 
events after treatment has not been elucidated2. Asymptomatic 
prostatitis (Category IV of the NIH Classification of Prostatitis)3 is a well-
recognised entity noted in TURP biopsy specimens. Pathological 
consensus dictates that chronic inflammation must typically involve the 
prostate in a peri-glandular distribution, to be considered prostatitis. 
Diffuse stromal infiltrates or focal lymphoid aggregates in the stroma 
may be seen ubiquitously, and are considered to be of no clinical 
significance4. Few studies exist on the influence of this chronic 
prostatitis seen after TURP on patient outcomes after the procedure. 
Bucuras et al compared two groups with and without chronic prostatitis 
in the TURP biopsy specimens and found no significant difference in 
intra-operative and post-operative complications between them5. A 
study by Doluoglu, however found prostatic inflammation to be a 
significant factor for the development of urethral stricture and bladder 
neck contractures after TURP6. Our study was conducted to look into 
this controversial issue and see if an association truly exists. 
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REVIEW OF LITERATURE 
 
The human prostate is an immunocompetent organ, harbouring a 
smattering of inflammatory cells that populate the stroma and the 
epithelium. As age increases, the number of T&B lymphocytes, 
macrophages and mast cells within the prostate also increases. Chronic 
inflammation of the prostate has a characteristic histological signature, 
consisting mainly of CD3+ and CD4+ T lymphocytes (70-80%), CD19 or 
CD20 B lymphocytes (10-15%) and macrophages (15%). 
 
Prostatic inflammation is a nebulous term, with no clear-cut definition as 
to what constitutes it, histologically. A clinical definition of what 
encompasses prostatitis is partly laid down in the chronic pelvic pain / 
CPPS syndrome classification system. Molecular studies have only now 
enabled the identification of the types of inflammatory cells that populate 
the prostate, leading to some clarity. The earliest attempt to arrive at an 
accepted histological classification of prostatitis was made by Kohnen at 
al in 1978. They described 6 morphologically distinct patterns (Figs. 1 & 
2) of prostatic inflammation based on analysis of prostatectomy 
specimens –     
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(i)  Segregated glandular inflammation,  
(ii)  Peri-glandular inflammation  
(iii) Diffuse stromal inflammation,  
(iv) Isolated stromal lymphoid nodule 
(v)   Acute necrotizing inflammation  
(vi) Localized granulomatous inflammation. 
Irrespective of the presence of disease, chronic prostatitis is most 
commonly characterized by a lymphocytic infiltrate in the stroma 
immediately adjacent to the prostatic acini, a finding re-established by 
Nickel et al6.  Stromal infiltrates often co-exist with peri-glandular peri-
glandular inflammation, but their presence can be ubiquitous8.  
Inflammatory cell infiltrates had been noted in the prostatic tissue of 
patients with BPH in Kohnen’s study, and there have been many 
studies which reveal that these two entities often co-exist8.  The clinical 
relevance of this association, however, remains a mystery.   
Evidence exists for chronic inflammation as an etiological agent in 
many human cancers like stomach, large bowel and liver. The 
temptation to draw a parallel for development of neoplasia in chronically 
inflamed prostates held immense appeal for many investigators, and a 
link between prostatitis and prostate cancer was sought10. 
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Prostatic inflammation was found in more than 2/3rds of men in the 
REDUCE trial. Prostatic tissue in BPH was found to have chronic 
inflammation in ~43% of specimens, as reported by Di Silverio8. Areas 
of chronic inflammation frequently occur in radical prostatectomy 
specimens, prostatic biopsies, and autopsy material9,10.  The link 
between the presence of inflammation, BPH has also been explored, 
with Nickel even questioning if it is the missing 'third' link in the 
pathophysiology of hyperplasia along with its static and dynamic 
components11. 
There thus exists a dichotomy in the world of prostatitis, with 
pathologists defining it as an increase in the prostatic parenchyma  
while the urologist’s view is a clinical one. The classical definition for 
the urologist has been a syndrome characterized by lower genitourinary 
tract pain/discomfort and inflammatory cells seen in the expressed 
prostatic secretions. These syndromes were together incorporated into 
a single classification of the chronic prostatitis/pelvic pain syndromes 
(CPPS) by the NIH group3. 
 
The NIH consensus classification of prostatitis syndromes includes 4 
categories: 
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I Acute bacterial prostatitis 
II Chronic bacterial prostatitis 
III Chronic prostatitis/chronic pelvic pain syndrome 
A. Inflammatory 
B. Non-inflammatory 
IV Asymptomatic inflammatory prostatitis 
 
 
Category IV of the NIH classification comprises prostatitis detected 
incidentally on biopsy, and is called asymptomatic prostatitis. Therapy 
is not deemed necessary for this group, as these patients are by 
definition asymptomatic. The incidence of asymptomatic prostatitis has 
been found to be 43-98% in surgically resected prostates for BPH11 .  
 
 The clinical significance of finding asymptomatic prostatitis in TURP 
specimens has not been clearly elucidated. BPH is the most common 
disease affecting old men with an estimated 70% incidence at 60-70 
years, with increasing incidence and prevalence with age12. As the 
14 
 
 
 
incidence increases, an increasing number of patients will eventually 
require surgery as an end-point of disease progression.  
 
TURP remains the gold standard treatment for surgical management of 
BPH. The likelihood that a person will require TURP increases by 6, 14 
and 8 times with each completed decade after 59 years. After its 
introduction in the early 20th century, the morbidity and mortality 
associated with TURP has steadily fallen with progressively increasing 
instrumental and technical advancements.13 The risk of intra-operative 
complications like cardiac events and TUR syndrome is small but real.14 
The advent of bipolar TURP technology arose from the need to 
overcome the peri-operative and post-operative morbidity of 
conventional monopolar TURP.     
Meatal stenosis and strictures of the urethra are major late 
complications after TURP. The former usually occur due to discrepancy 
in size between the resectoscope sheath and the meatal diameter 15. 
Urethral strictures, on the other hand are proposed to be caused by 
mechanical and thermal stress to the urethra, along with inappropriate 
lubrication, incorrect axial and rotating movements of the resectoscope, 
longer periods of operative time, and with prolonger catheterization 
times16.  The incidence of meatal stenosis /urethral strictures and 
bladder neck contractures in contemporary series   is reportedly to the 
tune of 2.2-9.8% and 0.3-9.2% respectively14. 
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With regards to bladder neck contractures after TURP, it has been 
suggested that performing a bladder neck incision after TURP in 
patients with small prostates may be beneficial18, 19.  
 
The role of chronic inflammation seen after TURP in influencing 
outcomes after TURP has not been extensively evaluated. Bucuras et 
al retrospectively analysed 200 consecutive cases of BPH with no 
history of chronic prostatitis. Two groups were identified from these 
depending on whether the prostatic tissue harboured inflammation or 
not. There were no significant differences concerning intra-operative 
and postoperative complications between the two groups, barring acute 
urinary retention, which was more frequently seen both before and after 
surgery in patients with prostatitis. The authors concluded that further 
studies were needed to elucidate this problem more clearly.20 
A similar study by Doluoglu et al was conducted to evaluate the 
relationship between pathologically proven prostatic inflammation and 
re operation rates due to stricture urethra and bladder neck stenosis 
occurring after TURP.  Retrospective data on 917 patients was 
reviewed with respect to the presence or absence of inflammation in 
the biopsy specimen after TURP. These two groups were compared 
with respect to the descriptive data and need for re-operation. It was 
found that the re operation rate in the group with prostatic inflammation 
was significantly higher than that without chronic prostatitis (29.8% vs. 
16 
 
 
 
8.6%, p=<0.0001). It was proposed that prostatic inflammation seen on 
TURP histopathology was an independent variable affecting the 
development of urethral stricture or bladder neck contracture.21   
  While considering the complications and pre-operative risk factors the 
use of pre-operative anticoagulant use, anti platelet use, pre-operative 
catheter placement, larger prostate size, use of monopolar /bipolar 
cautery etc. have all also been demonstrated to have an impact on 
outcome.22 
 
With increasing need for a standardized method of reporting 
classification, the Clavien system was introduced in 1992, and later 
modified in 2004.23 This modified Clavien- Dindo system was 
introduced across all surgical disciplines, including urology, improving 
the detection of often un-reported and minor complications. Improved 
detection thus culminated in less observation bias, especially in 
retrospective studies. Mamoulakis et al suggested the use of this 
system to allow for an objective, standardized and detailed comparison 
of reporting complications of TURP.24 The majority in their series were 
those with Grade 1 or Grade 2, with one death (Grade 5).  
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AIM 
 
1. To study the outcome variables between two patient cohorts with 
the absence or presence of inflammation identified histologically in 
their TURP specimens.  
2. To determine the role of asymptomatic prostatitis in the 
development of short term and long term complications after a 
TURP 
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PATIENTS AND METHODS 
 
DESIGN AND LOCATION:  
This hospital based historical cohort study was conducted at the 
Department of Urology, Christian Medical College, Vellore. 
 
PATIENTS:   
All patients who underwent a TURP in our hospital between 2005 and 
2010 who satisfied the following inclusion and exclusion criteria were 
recruited: 
INCLUSION CRITERIA: 
1. Patients with a minimum follow-up of 3 months. 
2. Patients whose biopsy showed BPH with/without glandular/peri-
glandular stromal inflammatory infiltrates suggestive of prostatitis. 
3. Absence of chronic perineal/pelvic pain ( i.e. patients classified to 
have Asymptomatic inflammatory Prostatitis - Category IV of the 
NIH Classification of Prostatitis)   
EXCLUSION CRITERIA: 
1. Patients undergoing TURP with a concomitant procedure (for 
eg.hernioplasty/circumcision/cystolitholapaxy). 
2. Patients who had a histological diagnosis of carcinoma prostate. 
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3. Prior history of urethral instrumentation. 
4. Biopsy patterns showing scattered/focal stromal inflammatory 
infiltrate without any acinar/peri-glandular involvement. 
 
DURATION:   
Patients operated at our institution between January 2005 and 
December 2010 were included. 
 
METHODOLOGY:  
Patients who underwent a TURP at our institute during the 
aforementioned study period and fulfilling the inclusion criteria detailed 
above were selected for inclusion in the study. Prior to surgery, all 
patients were subjected to a thorough history-taking & physical 
examination. IPSS, serum biochemistries, urine analysis, and urine 
cultures were documented. Serum PSA was not sent routinely. Patients 
on anti platelet therapy were asked to discontinue the drug for a period 
of a week pre-operatively. A detailed proforma was filled up for each 
patient recording the data to be assessed.  Informed consent was taken 
in the appropriate format. In accordance with institutional policy an IRB 
committee clearance was obtained for the study.  The TUR-P was 
performed using the same technique in all cases with the use of a 26F 
continuous irrigation resectoscope and with either a bipolar or 
monopolar energy source. A BNI was added to at the end of the TURP 
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in those noted to have a small gland intra operatively.   Patients with a 
biopsy showing presence/absence of inflammation who had a minimum 
of 3 months follow-up were included (150 in each cohort) and analysed. 
Re-interventions for complications were performed in the event that the 
patient presented at a later date with a poor flow, with uroflowmetry 
showing an average Q max of less than 10 ml/second.  
 
DETAILED METHODOLOGY: 
 
FOLLOW-UP: 
Only those patients having a minimum follow-up of 3 months after the 
TURP were included, as the mean time reported for complications like 
bladder neck contracture is reported as 2 months17.  
 
INDICATION FOR TURP 
These were classified as chronic retention, acute retention, acute on 
chronic retention, failure of medical management, obstructive 
nephropathy, recurrent urinary tract infections (UTIs), recurrent 
hematuria or highly bothersome LUTS. If more than one indication 
existed, the single most significant one was taken for consideration. 
 
 
 
22 
 
 
 
USE OF PRE-OPERATIVE 5 –ALPHA REDUCTASE INHIBITORS 
Prior use of any of the 5-Alpha reductase inhibitors (Finasteride or 
Dutasteride) either alone or in combination with alpha-blockers was 
noted. This was included due to the known effect of reduction in 
prostate gland volume associated with this class of drugs, which in turn 
could have an effect on outcomes after TURP.  
 
PRE-OPERATIVE URINARY CATHETER 
Presence or absence of a pre-operative urinary catheter was noted. 
 
CO-MORBIDITIES  
The associated patient risk factors which could affect peri-operative 
mortality/morbidity like diabetes mellitus, hypertension, ischaemic heart 
disease, chronic obstructive pulmonary disease, anticoagulant use, anti 
platelet use and chronic renal failure were noted. The patients were 
then grouped into those who had single, multiple, or no co morbidities 
in the final analysis. 
 
DIGITAL RECTAL EXAMINATION 
Pre-operative DRE assessment of the gland size was recorded.  
 
I 
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IMMEDIATE POST-OPERATIVE COMPLICATION 
To ensure for uniformity in reporting complications, the modified 
Clavien system for TURP proposed by Mamoulakis et al. was used.24 
The complications were graded from Clavien grade 1 through grade 5. 
 
LONG TERM COMPLICATIONS 
The occurrence of meatal stenosis, urethral stricture, bladder neck 
contracture or recurrent adenoma was noted on follow-up. All these 
patients underwent re interventions for the complication (viz. Meatal 
dilatation/meatoplasty/endoscopic internal urethrotomy EIU /urethral 
Teflon dilatation or bladder neck incision). 
 
RESECTED GLAND 
The actual weight of the resected prostatic tissue (in grams) was 
recorded.  
 
PRESENCE OF PROSTATITIS 
The presence of inflammatory infiltrate in a location characteristic for 
prostatitis (viz. periglandular stroma, glandular epithelium and 
intraglandular luminal sites) was identified based on the biopsy report 
and patients with/without prostatic inflammation and adequate follow-up 
were included, to attain the sample size of 300. Presence of scattered  
or focal  stromal inflammatory infiltrates alone was not included.  
24 
 
 
 
 
PRE-OPERATIVE URINE CULTURE 
This was obtained as a suprapubic aspirate/ mid-stream clean catch or 
catheter sample. Patients with significant pre-operative urine cultures 
were treated for a minimum of 3 days with a course of culture-specific 
antibiotics. Colony counts of >100,000 c.f.u was considered significant.  
 
 
POST-OPERATIVE URINE CULTURE 
This was obtained after the TURP procedure either as a voided sample 
or a catheter sample in those who had failed bedside TWOC post-
operatively. Patients with significant post-operative urine cultures were 
treated for a minimum of 3 days with a course of culture-specific 
antibiotics. Colony counts of >100,000 c.f.u were considered significant.  
 
STATISTICAL ANALYSIS: 
Sample size calculation: Based on previous studies in contemporary 
literature14,17 the expected mean difference in complications between 
those with (10%) and without (2%) prostatic inflammation was kept at 
6%. The number needed to detect a significant difference, keeping the 
power at 80%, was calculated to be a minimum of 140 in each arm. We 
finally included 300 subjects (150 in each group) in the study.   
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Statistical package for social science (SPSS) version 16.0 was used for 
statistical analysis.  
The results were grouped into two groups: Group A included patients 
with a pattern of prostatic inflammation seen in the biopsy specimen 
after TURP and Group B included patients in whom there was none. .  
Student’s T-test was used to compare quantitative variables between 
the groups and the Pearson’s Chi-squared test was used to analyse 
association with complications qualitatively. Mean ± standard deviations 
were used for normally distributed data and median & range (min – 
max) was used for skewed data to avoid the outlier effect. The Mann-
Whitney U test was used to assess variables not following a normal 
distribution. A p value of ≤ 0.05 was taken as significant. 
 
 
 
 
 
                       
 
 
 
 
 
                                    RESULTS 
 
 
Total number of patients who underwent a TURP between 
2005 and 2010  
n = 945 
 
 
 
Biopsy showing BPH 
n = 822 
 
 
 
 
 
Did not me  
criteri
 
 
 
 
 
 
 
TABLE 1 
 
Study population 
n = 300  
et inclusion
a= 52226 
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TABLE 1 
 
 
Variable 
Group A  
(Pi-) 
 
Mean±S.D. 
Group B 
 (Pi+) 
 
Mean±S.D. 
 
p value 
Age  
(years) 
63.79+8.04 64.41+7.76 0.49 
DRE gland size 
(grams) 
31.83+10.5 31.92+9.93 0.90 
Resected 
weight (grams)
20.9+18.15 23.2+14.95 0.16 
Hospital stay   
(days) 
6.21+2.57 6.17+2.21 0.38 
Follow-up 
(months) 
24.9+21.07 20.9+18.15 0.12 
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TABLE 2 
 
 
Comorbidities 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
 
p value 
None 44% 32% 
Single 32% 48% 
Multiple 24% 20% 
 
1.08 
 
 
 
TABLE 3 
 
Preoperative 
ARI use 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
 
p value 
Used 20% 14% 
Not used 80% 86% 
1.94 
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TABLE 4 
 
Preoperative 
catheter 
 
Group A 
(Pi-) 
% 
Group B 
(Pi+) 
% 
 
p value 
Absent 54% 53% 
Present 46% 47% 
 
0.45 
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TABLE 5 
 
p value Indication Group A  
(Pi-) 
%
Group B 
 (Pi+) 
%
Chronic 
retention 
9.4% 11.3% 
Acute retention 18.8% 21.3% 
Acute on 
chronic 
retention 
17.4% 15.3% 
Failure of 
medical 
management 
43% 32% 
Obstructive 
nephropathy 
0% 0.7% 
 
Recurrent UTI 2% 3.3% 
Recurrent 
hematuria 
1.3% 2.7% 
Bothersome 
LUTS 
8.1% 13% 
0.4 
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TABLE 6 
Energy source Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
Monopolar 91.3% 91.3% 
Bipolar 8.7% 8.7% 
0.58 
 
TABLE 7 
Blood 
transfusion 
intra-
operatively 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
 
p value 
Given 96% 4% 
Not given 93% 7% 
1.08 
 
TABLE 8 
Surgery 
performed 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
TURP 95.3% 94% 
TURP + BNI 4.7% 6% 
0.39 
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TABLE 9 
 
Clavien Grade 
1 
Complications 
 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
None 81% 70.7% 
Hematuria  1.4% 3.3% 
Clot retention 2% 1.3% 
Blocked 
catheter 
0% 0.7% 
Bedside failed 
TWOC 
2% 2.7% 
Transient rise 
of creatinine 
2% 0% 
Post-operative 
UTI requiring 
antibiotics 
10.8% 21.3% 
0.06 
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TABLE 10 
 
Clavien Grade 2 
Complication 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
None 95.3% 97.3% 
Hemorrhage 
requiring blood 
transfusion 
2.7% 1.3% 
UTI with 
septicemia 
0.7% 1.3% 
Supraventricular 
tachycardia 
1.3% 0% 
Pulmonary 
embolism 
0% 0% 
0.39 
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TABLE 11 
 
Clavien Grade 
3 
Complication 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
No  
re-exploration 
97% 98.7% 
Re-exploration 
with anesthesia 
3% 1.3% 
0.248 
 
 
TABLE 12 
 
Clavien Grade 
4 
Complication 
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
TUR Syndrome 4% 1.3% 
MI 0% 0% 
0.14 
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TABLE 13 
Long term 
complications
Group A  
(Pi-) 
% 
Group B 
 (Pi+) 
% 
p value 
Meatal stenosis 2% 3.3% 0.51 
Stricture 
urethra 
6%% 6.7% 0.64 
Bladder neck 
contracture 
3.3% 5.3% 0.72 
Recurrent 
adenoma 
2% 3.3% 0.51 
 
TABLE 14 
OVERALL INCIDENCE OF LONG TERM COMPLICATIONS 
 
LONG TERM COMPLICATION Total n= 300(%) 
Meatal stenosis 7(2.3%) 
Urethral stricture 18(6%) 
Bladder neck contracture 11(4.3%) 
Recurrent adenoma 8(2.6%) 
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RESULTS 
The two groups of patients were divided based on the absence or 
presence of prostatitis. 
 
GROUPA GROUPB 
Prostatitis absent (Pi-) Prostatitis present (Pi+) 
 
PATIENT PROFILE 
The study group comprising 300 patients had an overall mean age of 
64 years (range 47-88).  All the patients had an average hospital stay of 
6 days, including the dates of admission and discharge. The mean 
gland size of the group was 32 grams and the mean resected weight 
was 22 grams. We had kept a minimum follow-up criterion as 3 months, 
and the mean follow-up duration noted in our study was 22 months. 
The longest duration of follow-up among all the groups was 72 months.  
 
The baseline demographic data compared between Group A and B 
revealed a similar distribution of age, gland size on DRE, hospital stay, 
and follow- up, suggesting both the groups were homogeneous in 
composition.  
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The comorbidities between the groups showed a similar pattern. There 
was a slightly higher incidence of patients with multiple co-morbidities in 
Group A (24%). Group B showed a higher incidence of patients with a 
single co-morbidity, the most common of which was hypertension. 
Overall the most common co-morbidity among our patients was 
hypertension, followed closely by diabetes mellitus. COAD, ischemic 
heart disease, chronic kidney disease and anti-platelet use were the 
other co-morbidities noted  
in the study group, but these were not analysed individually.  
 
A small proportion of our patients had been on Alpha-reductase 
inhibitors preoperatively. This was uniform in both the groups- 14% and 
20% in group A and B respectively.  The remainder either did not report 
use of this drug or had not been started on it. The difference between 
use in group A and B was not significant  
(p= 1.94).  
Around 50% of the patients in both group A and group B were on 
catheters preoperatively , showing that both groups has a similar 
patient profile, preventing potential skewing of data. 
 
The most common indication between for both groups was failed 
medical management, which was slightly more common in group A 
(43% vs. 32%). This was not however a significant difference. The 
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other indications in decreasing order of importance were acute 
retention, chronic retention, acute on chronic retention, recurrent 
hematuria and recurrent hematuria. There were no cases of obstructive 
nephropathy in group A, but this was again not of significant on 
comparison between the two groups.  
 
The use of monopolar and bipolar current as energy sources showed 
remarkable similarity between the two groups. Monopolar cautery was 
the predominant source of energy used, with the use of bipolar was 
approximately 9% in both the groups.  
 
The intra-operative use of blood products between the two groups also 
was similar , with an overall average transfusion rate of ~5%. The 
transfusion given post-operatively due to hematuria in the ward was 
recorded separately using the Clavien classification ( vide infra).  
 
The surgery performed in most cases was a TURP , which had a 
similar incidence in groups A and B. The addition of a BNI failed to 
make a difference in outcome between the two groups. The overall 
incidence of concomitant BNI performed in our series was 5%.  
 
On analysis of the short term complications as recorded by the Clavien 
system , it was noted that the most common Clavien complication was 
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the post-operative use of antibiotics for UTIs. These were either 
symptomatic or asymptomatic with significant colony counts, which 
were treated with a course of antibiotics. Though a seemingly higher 
incidence of post-operative UTIs was seen in group B , this difference 
was not statistically significant. The next most common Clavien 1 
complication was hematuria noted in the post-operative period, which 
required irrigation and removing the catheter a few days later , as and 
when the catheter effluent was clear. The incidence in the two groups 
of bedside failed TWOC was 2% and 3% in the groups. These patients 
were recatheterised and had a successful trial void at a later date on an 
OPD basis. There was a small 2% incidence of transient creatinine rise 
in group A, which again was not significant.  Overall the two groups 
showed no significant difference in Clavien 1 complications.  
 
Clavien grade 2 complications were again rare, with the most common 
one being hematuria requiring blood transfusion in the post-operative 
period. This incidence in our series was 2.7% in group A and 1.3% in 
group B, with the mean overall postoperative transfusion rate being 
1.5%.  A small percent of both the groups progressed to have UTI  with 
septicemia, requiring a two-week course of antibiotics, This was seen 
with a similar incidence in both the groups, and the the presence of 
inflammation in the biopsy did not have any statistically significant 
association with the occurrence of this morbidity. 2 patients developed 
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ECG changes   intra operatively,  requiring a shift to SICU in the 
immediate post-operative period, These were not associated with any 
cardiac enzyme elevations and they subsequently had no 
complications. There was no incidence of pulmonary embolism in both 
the groups. The overall p value between the two Clavien grade 2 
groups was 0.9, suggesting no statistically significant difference.   
 In the post-operative period 3% of patients in Group A required re-
exploration for clot evacuation subsequent to postoperative bleeding . 
The corresponding  incidence in group B was 1,3%, showing that there 
was no difference in Clavien grade 3 complication rates.  
 Group A was noted to have a 4% incidence in postoperative TUR 
syndrome, though no obvious cause was evident for this. On statistical 
analysis failed to highlight a possible association prostatitis and the 
occurrence of TUR syndrome. None of the patients had an MI in either 
of the groups.  
 
There were no Clavien grade 5 complications reported in either of the 
groups, making a comparison impossible.  
Finally, analysis of the long term complications between both group A 
and group B (with respect to meatal stenosis, urethral stricture 
formation, bladder neck contracture or recurrent adenoma) also 
showed no statistical  significance.  
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DISCUSSION  
 
The significance of finding chronic prostatitis in the biopsy specimens of  
patients undergoing a TURP has been debated.  
While some authors reported an association with outcomes, other 
researchers failed to demonstrate a definite link of association between 
this pathological entity and clinical outcomes after TURP.  
The study was initiated to address the role of asymptomatic prostatitis 
found incidentally on TURP specimens and  to look for an association 
with either long term or short term outcomes. Our baseline 
demographic data showed that both the groups (Group A and Group B) 
had a similar clinical profile , suggesting that both the study populations 
were homogeneous. The  placement of pre-operative catheter, 5ARI 
use, presence of single    versus multiple comorbidities  , pre-operative 
positive urine cultures , gland size, energy source used ( monopolar or 
bipolar )  or resected glandular tissue weight did show any statistical 
significance between the two groups. The immediate short term 
complications were stratified into 5 Clavien Grades , and these also 
failed to show any association with  the presence or absence of 
asymptomatic prostatitis.  Finally , the occurrence of long term 
complications (which have been hypothesized to be the  sequelae of 
chronic inflammation and irritation) was found to be the same across 
both the groups, putting the hypothesis of inflammation as a cause for 
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long term complications into question. The overall incidence of both 
long term  complication in our case series(2.3%, 6%, 4.3% and 2.6 % 
for meatal stenosis , urethral stricture, bladder neck contracture and 
recurrent adenoma  respectively) is comparable with that found in 
contemporary series on TURP complication rates14.  
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CONCLUSIONS 
 
1. Presence of prostatitis on histopathology did not alter the outcome 
of patients who underwent a TURP. 
2. Short term and long term complications of TURP had no 
association with the finding of prostatitis in the biopsy. 
Asymptomatic prostatitis was merely a co-incidental finding in the 
biopsy of patients undergoing a TURP.  
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PROFORMA 
 
1. Name: 
2. Age: 
3. Hospital number: 
4. Address: 
5. Phone number: 
6. Hospital stay(days): 
7. Follow-up duration (months): 
8. Pre-operative positive urine culture: Y/N 
9. Pre-operative antibiotics course:Y/N 
10. Indication for TURP: Chronic retention/ acute retention/ acute on  
      chronic retention/ failed medical management/ poor flow/ recurrent  
      UTI/ recurrent hematuria/ bothersome LUTS 
11. Co morbidities: Absent/single/multiple {Specific details:                   } 
12. Pre-operative urinary catheter: Y/N 
13. DRE gland size (grams): 
14. Energy source: Monopolar/bipolar diathermy 
15. Blood transfusion: Y/N 
16. Gland resected (grams): 
17. Biopsy showing chronic prostatitis: Y/N 
18. Post-operative positive urine culture: Y/N 
19. Post-operative complications: Y/N 
20. Clavien grade of complication: 1/2/3/4/5 {Specific details:                   } 
21. Long- term complications: Meatal stenosis/urethral stricture/bladder neck 
contracture/residual prostate 
